EC-18
EC-18 is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
Clinical Trials (8)
Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers
Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers
A Safety and PK Study of EC-18 in Healthy Subjects
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8